ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/018/SRR26949718/SRR26949718_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/016/SRR26949716/SRR26949716_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/012/SRR26949712/SRR26949712_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/010/SRR26949710/SRR26949710_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/014/SRR26949714/SRR26949714_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/018/SRR26949718/SRR26949718_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/015/SRR26949715/SRR26949715_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/010/SRR26949710/SRR26949710_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/012/SRR26949712/SRR26949712_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/013/SRR26949713/SRR26949713_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/017/SRR26949717/SRR26949717_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/015/SRR26949715/SRR26949715_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/011/SRR26949711/SRR26949711_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/013/SRR26949713/SRR26949713_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/016/SRR26949716/SRR26949716_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/017/SRR26949717/SRR26949717_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/014/SRR26949714/SRR26949714_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR269/011/SRR26949711/SRR26949711_1.fastq.gzprimaryOK200GenomicsClemson Universityhttps://www.ebi.ac.uk/ena/browser/view/PRJNA1045285We exposed developmental human cardiac organoids to paroxetine at different concentrations to evaluate the toxic effects of paroxetine at different cardiac life-stages using transcriptomic analysis.ENAtrans-(+)-Isomer, Paroxetine Hydrochloride Hemihydrate, FG7051, 4-(methylenedioxy)phenoxy)methyl)piperidine, (-)-(3S, BRL 29060, Paroxetine Hydrochloride, Aropax, FG 7051, 3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine, Paroxetine Acetate, Paroxetine Maleate, cis-(-)-Isomer, 4R)-4-(p-fluorophenyl)-3-((3, Piperidine, paroxetinum, Paroxetine, 3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, cis-(+)-Isomer, Seroxat, (3S-trans)-3-((1, Organoid, BRL29060., (3S-trans)-, FG-7051, BRL-29060, 3-((1, paroxetina, Hemihydrate, Paroxetine Hydrochloride Anhydrous, PaxilfalseCardiac organoid exposed to paroxetine2023-11-282023-11-28PRJNA1045285